High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update;Hochdosierte intravenöse immunglobuline in der behandlung der multiplen sklerose. Update über neue studien

Nervenarzt

Volumn 76, Issue 10, 2005, Pages 1267-1272

  Stangel, M ^a   Gold, R ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Intravenous immunoglobulin; Relapsing remitting multiple sclerosis; Secondary progressive multiple sclerosis; Therapy studies

Indexed keywords

IMMUNOGLOBULIN; STEROID;

DATA ANALYSIS; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; HUMAN; INCIDENCE; MULTIPLE SCLEROSIS; PUERPERIUM; RELAPSE; REVIEW;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 26444565750     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-1935-4     Document Type: Review

References (15)

1. Achiron A, Kishner I, Dolev M et al. (2004) Effect of intravenous immunoglobulin treatment on pregnancy and post-partum related relapses in multiple sclerosis. J Neurol 251:1133-1137
2. Achiron A, Kishner I, Sarova-Pinhas I et al. (2004) Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis. A randomized, double-blind, placebo-controlled trial. Arch Neurol 61:1515-1520
3. Confavreux C, Hutchinson M, Hours MM et al. (1998) Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339:285-291
4. Filippi M, Rocca MA, Pagani E et al. (2004) European study on intravenous immunoglobulin in multiple sclerosis. Arch Neurol 61:1409-1412
5. Haas J (2000) High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 6(Suppl 2):S18-S20
6. Hommes OR, Sorensen PS, Fazekas F et al. (2004) Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. Lancet 364:1149-1156
7. Kocer B, Yildirim-Gürel S, Tali ET et al. (2004) The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to their in evaluating the efficacy of intravenous immunoglobulin G. Neuroradiology 46:287-290
8. Multiple Sclerosis Therapy Consensus Group (2004) Escalating immunotherapy of multiple sclerosis - new aspects and practical application. J Neurol 251:1329-1339
9. Multiple Sklerose Therapie Konsensus Gruppe (2002) Immunmodulatorische Stupentherapie der multiplen Sklerose. Neue Aspekte und praktische Umsetzung, März 2002. Nervenarzt 73:556-563
10. Orvieto R, Achiron R, Rotstein Z et al. (1999) Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol 82:191-194
11. Roed HG, Langkilde A, Sellebjerg FT et al. (2005) A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 64:804-810
12. Sorensen PS, Haas J, Sellebjerg F et al. (2004) IV immunoglobulins as add-on treatment to methyl-prednisolone for acute relapses in MS. Neurology 63:2028-2033
13. Stangel M, Gold R (2004) Einsatz von i.v. Immunglobulinen in der Neurologie - Evidenzbasierter Konses. Nervenarzt 75:801-815
14. Stangel M, Hartung H-P (2002) Despair of repair. Immunoglobulins in multiple sclerosis. J Neurol Neurosurg Psychiatry 72:1-4
15. Visser LH, Beekman R, Tijssen CC et al. (2004) A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination i.v methylprednisolone in the treatment of relapses in patients with MS. Mult Scler 10:89-91